A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2018
At a glance
- Drugs RAD 140 (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; First in man
- Sponsors Radius Health Inc.
- 01 Mar 2018 According to a Radius Health media release, data from the study is expected by the end of 2018.
- 29 Sep 2017 According to a Radius Health media release, the first patient has been enrolled in this trial. Additional details are anticipated in peer-reviewed publications and results are anticipated at upcoming scientific conferences.
- 29 Sep 2017 Status changed from not yet recruiting to recruiting, as reported in a Radius Health Inc. media release.